Edgen Stock·Dec 12 2025, 22:31Back
Vor Biopharma Stock Soars On Telitacicept Data
Edgen Stock·Dec 12 2025, 22:31
[1] Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some - Fierce Biotech (https://www.fiercebiotech.com/biotech/eli-lil ...)[2] Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test - Fierce Biotech (https://www.fiercebiotech.com/biotech/rezolut ...)[3] Tivic Health (Nasdaq: TIVC) adds CDMO unit to speed Entolimod manufacturing - Stock Titan (https://www.stocktitan.net/news/TIVC/tivic-ac ...)
